What is Epocrates?
Epocrates is a leading developer of medical applications designed for U.S. physicians. Its platform provides critical clinical intelligence, practice management tools, and facilitates health industry engagement directly at the point of care. By offering these essential resources, Epocrates aims to enhance physician efficiency and improve patient outcomes, positioning itself as a vital digital health partner for medical professionals.
How much funding has Epocrates raised?
Epocrates has raised a total of $138M across 4 funding rounds:
Series A
$10.8M
Series B
$35M
Series C
$6.4M
Stock Offering
$85.8M
Series A (1999): $10.8M, investors not publicly disclosed
Series B (2000): $35M led by InterWest Partners, Draper Fisher Jurvetson (DFJ), Three Arch Partners, Sprout Group, and Bay City Capital
Series C (2002): $6.4M supported by Sprout Group, Bay City Capital, InterWest Partners, Draper Fisher Jurvetson (DFJ), and Three Arch Partners
Stock Issuance/Offering (2011): $85.8M, investors not publicly disclosed
Key Investors in Epocrates
InterWest Partners
InterWest Partners is a venture capital firm that has historically invested in various technology sectors, including healthcare and life sciences, providing capital for companies aiming for significant market impact.
Draper Fisher Jurvetson (DFJ)
Draper Fisher Jurvetson (DFJ) is a prominent venture capital firm known for backing transformative technology companies across diverse industries, with a strong track record in early-stage investments.
Three Arch Partners
Three Arch Partners is a venture capital firm specializing in the healthcare sector, focusing on medical devices and healthcare services, and actively creating and funding new companies to address unmet clinical needs.
What's next for Epocrates?
With the recent injection of major strategic capital, Epocrates is poised to further solidify its market position. The company is likely to focus on enhancing its existing suite of clinical intelligence and practice management tools, potentially expanding its reach within the healthcare ecosystem. Future developments may include deeper integration with athenahealth's broader offerings and the exploration of new digital health solutions to meet the evolving needs of physicians and healthcare providers.
See full Epocrates company page
